Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques

PLoS Pathogens

Volumn 12, Issue 1, 2016, Pages

  Pandrea, Ivona ^a,b   Xu, Cuiling ^a   Stock, Jennifer L ^a   Frank, Daniel N ^c   Ma, Dongzhu ^a,b   Policicchio, Benjamin B ^a   He, Tianyu ^a   Kristoff, Jan ^a   Cornell, Elaine ^d   Haret Richter, George S ^a   Trichel, Anita ^a,b   Ribeiro, Ruy M ^e   Tracy, Russell ^d   Wilson, Cara ^c   Landay, Alan L ^f   Apetrei, Cristian ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e LOS ALAMOS NATIONAL LABORATORY   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; RIFAXIMIN; SALAZOSULFAPYRIDINE; THROMBOPLASTIN; ANTIINFECTIVE AGENT; RIFAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; COMORBIDITY; CONTROLLED STUDY; FLOW CYTOMETRY; HYPERCOAGULABILITY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACACA NEMESTRINA; MALE; MICROBIOME; NONHUMAN; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIRUS REPLICATION; ANIMAL; COMPLICATION; DRUG EFFECTS; INTESTINE; MICROBIOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; THROMBOPHILIA;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINES; MACACA NEMESTRINA; MALE; RIFAMYCINS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SULFASALAZINE; THROMBOPHILIA;

EID: 84956730438     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005384     Document Type: Article

References (89)

1. Douek DC, Roederer M, Koup RA, (2009) Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med 60: 471–484. doi: 10.1146/annurev.med.60.041807.123549 18947296
2. Anthony KB, Yoder C, Metcalf JA, DerSimonian R, Orenstein JM, et al. (2003) Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. J Acquir Immune Defic Syndr 33: 125–133. 12794543
3. Deeks SG, (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62: 141–155. doi: 10.1146/annurev-med-042909-093756 21090961
4. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, et al. (2003) T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 187: 1534–1543. 12721933
5. Brenchley JM, Paiardini M, (2011) Immunodeficiency lentiviral infections in natural and non-natural hosts. Blood 118: 847–854. doi: 10.1182/blood-2010-12-325936 21505193
6. Pandrea I, Apetrei C, (2010) Where the wild things are: Pathogenesis of SIV infection in African nonhuman primate hosts. Curr HIV/AIDS Reports 7: 28–36. doi: 10.1007/s11904-009-0034-8 20425055
7. Silvestri G, Paiardini M, Pandrea I, Lederman MM, Sodora DL, (2007) Understanding the benign nature of SIV infection in natural hosts. J Clin Invest 117: 3148–3154. 17975656
8. Pandrea I, Sodora DL, Silvestri G, Apetrei C, (2008) Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts. Trends Immunol 29: 419–428. doi: 10.1016/j.it.2008.05.004 18676179
9. VandeWoude S, Apetrei C, (2006) Going wild: Lessons from T-lymphotropic naturally occurring lentiviruses. Clin Microbiol Rev 19: 728–762. 17041142
10. Pandrea I, Silvestri G, Onanga R, Veazey RS, Marx PA, et al. (2006) Simian immunodeficiency viruses replication dynamics in African non-human primate hosts: common patterns and species-specific differences. J Med Primatol 35: 194–201. 16872282
11. Ma D, Jasinska A, Kristoff J, Grobler JP, Turner T, et al. (2013) SIVagm infection in wild African green monkeys from South Africa: epidemiology, natural history, and evolutionary considerations. PLoS Pathog 9: e1003011. doi: 10.1371/journal.ppat.1003011 23349627
12. Gaufin T, Pattison M, Gautam R, Stoulig C, Dufour J, et al. (2009) Effect of B-cell depletion on viral replication and clinical outcome of simian immunodeficiency virus infection in a natural host. J Virol 83: 10347–10357. doi: 10.1128/JVI.00880-09 19656874
13. Gaufin T, Ribeiro RM, Gautam R, Dufour J, Mandell D, et al. (2010) Experimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication. Retrovirology 7: 42. doi: 10.1186/1742-4690-7-42 20459829
14. Apetrei C, Sumpter B, Souquiere S, Chahroudi A, Makuwa M, et al. (2011) Immunovirological analyses of chronically simian immunodeficiency virus SIVmnd-1- and SIVmnd-2-infected mandrills (Mandrillus sphinx). J Virol 85: 13077–13087. doi: 10.1128/JVI.05693-11 21957286
15. Apetrei C, Gautam R, Sumpter B, Carter AC, Gaufin T, et al. (2007) Virus subtype-specific features of natural simian immunodeficiency virus SIVsmm infection in sooty mangabeys. J Virol 81: 7913–7923. 17507488
16. Kristoff J, Haret-Richter G, Ma D, Ribeiro RM, Xu C, et al. (2014) Early blockade of microbial translocation positively impacts the natural history of SIV infection. J Clin Invest 124: 2802–2806.
17. Mandell D, Kristoff J, Gaufin T, Gautam R, Ma D, et al. (2014) Determinants of increased pathogenicity upon simian immunodeficiency virus cross-species transmission from natural hosts. J Virol 88: 6778–6792.
18. Wijewardana V, Kristoff J, Xu C, Ma D, Haret-Richter G, et al. (2013) Kinetics of myeloid dendritic cell trafficking and activation: Impact on progressive, nonprogressive and controlled SIV infections. PLoS Pathog 9: e1003600. doi: 10.1371/journal.ppat.1003600 24098110
19. International AIDS Society Scientific Working Group on HIV CureDeeks SG, Autran B, Berkhout B, Benkirane M, et al. (2012) Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 12: 607–614. doi: 10.1038/nri3262 22814509
20. Clements JE, Gama L, Graham DR, Mankowski JL, Zink MC, (2011) A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system. Curr Opin HIV AIDS 6: 37–42. doi: 10.1097/COH.0b013e3283412413 21242892
21. Deeks SG, Lewin SR, Havlir DV, (2013) The end of AIDS: HIV infection as a chronic disease. Lancet 382: 1525–1533. doi: 10.1016/S0140-6736(13)61809-7 24152939
22. Brenchley JM, Douek DC, (2012) Microbial translocation across the GI tract. Annu Rev Immunol 30: 149–173. doi: 10.1146/annurev-immunol-020711-075001 22224779
23. Brenchley JM, Price DA, Douek DC, (2006) HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7: 235–239. 16482171
24. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365–1371. 17115046
25. Sandler NG, Douek DC, (2012) Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol 10: 655–666. doi: 10.1038/nrmicro2848 22886237
26. Gordon S, Klatt NR, Milush JM, Engram J, Dunham RM, et al. (2007) Severe depletion of mucosal CD4+ T cells in AIDS-free SIV-infected sooty mangabeys. J Immunol 179: 3026–3034.
27. Pandrea I, Gautam R, Ribeiro R, Brenchley JM, Butler IF, et al. (2007) Acute loss of intestinal CD4+ T cells is not predictive of SIV virulence. J Immunol 179: 3035–3046.
28. Ma D, Jasinska AJ, Feyertag F, Wijewardana V, Kristoff J, et al. (2014) Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild. J Virol 88: 5687–5705. doi: 10.1128/JVI.03606-13 24623416
29. Pandrea I, Cornell E, Wilson C, Ribeiro RM, Ma D, et al. (2012) Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates. Blood 120: 1357–1366. doi: 10.1182/blood-2012-03-414706 22653975
30. Pandrea I, Gaufin T, Brenchley JM, Gautam R, Monjure C, et al. (2008) Cutting edge: Experimentally induced immune activation in natural hosts of simian immunodeficiency virus induces significant increases in viral replication and CD4+ T cell depletion. J Immunol 181: 6687–6691. 18981083
31. Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, et al. (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362: 1071–1081. doi: 10.1056/NEJMoa0907893 20335583
32. Das KM, (1989) Sulfasalazine therapy in inflammatory bowel disease. Gastroenterol Clin North Am 18: 1–20. 2563989
33. Das KM, (1983) Pharmacotherapy of inflammatory bowel disease. Part 1. Sulfasalazine. Postgrad Med 74: 141–148, 150–141. 6139795
34. Brenchley JM, Douek DC, (2008) HIV infection and the gastrointestinal immune system. Mucosal Immunol 1: 23–30. doi: 10.1038/mi.2007.1 19079157
35. Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, et al. (2010) Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 6: e1001052. doi: 10.1371/journal.ppat.1001052 20808901
36. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, et al. (2008) Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 5: e203. doi: 10.1371/journal.pmed.0050203 18942885
37. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859–870. 10068581
38. Giorgi JV, Lyles RH, Matud JL, Yamashita TE, Mellors JW, et al. (2002) Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 29: 346–355. 11917238
39. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, et al. (2003) Persistent immune activation in HIV-1 infection is associated with progression to AIDS. Aids 17: 1881–1888. 12960820
40. Rodriguez B, Sethi AK, Cheruvu VK, Mackay W, Bosch RJ, et al. (2006) Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. Jama 296: 1498–1506. 17003398
41. Sandler NG, Wand H, Roque A, Law M, Nason MC, et al. (2011) Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 203: 780–790. doi: 10.1093/infdis/jiq118 21252259
42. Funderburg NT, Mayne E, Sieg SF, Asaad R, Jiang W, et al. (2010) Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood 115: 161–167. doi: 10.1182/blood-2009-03-210179 19828697
43. Sandler NG, Zhang X, Bosch RJ, Funderburg NT, Choi AI, et al. (2014) Sevelamer does not decrease lipopolysaccharide or soluble CD14 but does decrease soluble tissue factor, LDL, and oxidized LDL levels in untreated HIV infection. J Infect Dis: in press.
44. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200: 749–759. 15365096
45. Li Q, Duan L, Estes JD, Ma ZM, Rourke T, et al. (2005) Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434: 1148–1152. 15793562
46. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, et al. (2005) Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093–1097. 15793563
47. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, et al. (2004) Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200: 761–770. 15365095
48. Cassol E, Rossouw T, Seebregts C, Cassol S, (2011) Microbial translocation: a marker of advanced HIV-1 infection and a predictor of treatment failure? J Infect Dis 203: 747–748. doi: 10.1093/infdis/jiq109 21278212
49. D'Ettorre G, Douek D, Paiardini M, Ceccarelli G, Vullo V, (2012) Microbial translocation and infectious diseases: what is the link? Int J Microbiol 2012: 356981. doi: 10.1155/2012/356981 23091494
50. Leinert C, Stahl-Hennig C, Ecker A, Schneider T, Fuchs D, et al. (2010) Microbial translocation in simian immunodeficiency virus (SIV)-infected rhesus monkeys (Macaca mulatta). J Med Primatol 39: 243–251. doi: 10.1111/j.1600-0684.2010.00429.x 20618590
51. Naranbhai V, Samsunder N, Sandler NG, Roque A, Abdool Karim Q, et al. (2013) Neither microbial translocation nor TLR responsiveness are likely explanations for preexisting immune activation in women who subsequently acquired HIV in CAPRISA 004. J Acquir Immune Defic Syndr 63: 294–298. doi: 10.1097/QAI.0b013e31828e604b 23481666
52. Redd AD, Gray RH, Quinn TC, (2011) Is microbial translocation a cause or consequence of HIV disease progression? J Infect Dis 203: 744–745; author reply 746. doi: 10.1093/infdis/jiq107 21220777
53. Klatt NR, Canary LA, Vanderford TH, Vinton CL, Engram JC, et al. (2012) Dynamics of simian immunodeficiency virus SIVmac239 infection in pigtail macaques. J Virol 86: 1203–1213. doi: 10.1128/JVI.06033-11 22090099
54. Klatt NR, Harris LD, Vinton CL, Sung H, Briant JA, et al. (2010) Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection. Mucosal Immunol 3: 387–398. doi: 10.1038/mi.2010.14 20357762
55. Eitner F, Cui Y, Hudkins KL, Schmidt A, Birkebak T, et al. (1999) Thrombotic microangiopathy in the HIV-2-infected macaque. Am J Pathol 155: 649–661. 10433958
56. Shafran I, Burgunder P, (2008) Rifaximin for the treatment of newly diagnosed Crohn's disease: a case series. Am J Gastroenterol 103: 2158–2160. doi: 10.1111/j.1572-0241.2008.01982_16.x 18796124
57. Schmidt C, Fels T, Baumeister B, Vetter H, (1996) The effect of 5-aminosalicylate and para-aminosalicylate on the synthesis of prostaglandin E2 and leukotriene B4 in isolated colonic mucosal cells. Curr Med Res Opin 13: 417–425. 8862941
58. van Hees PA, (1987) Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease. Acta Gastroenterol Belg 50: 555–559. 2902723
59. Deeks SG, Tracy R, Douek DC, (2013) Systemic effects of inflammation on health during chronic HIV infection. Immunity 39: 633–645. doi: 10.1016/j.immuni.2013.10.001 24138880
60. Vesterbacka J, Barqasho B, Haggblom A, Nowak P, (2015) Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy. AIDS Res Hum Retroviruses 31: 830–836. doi: 10.1089/AID.2014.0366 26059763
61. Boisvert M, Cote S, Vargas A, Pasvanis S, Bounou S, et al. (2008) PGJ2 antagonizes NF-kappaB-induced HIV-1 LTR activation in colonic epithelial cells. Virology 380: 1–11. doi: 10.1016/j.virol.2008.07.023 18755491
62. Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ, (2002) Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cell Immunol 215: 61–71. 12142037
63. Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, et al. (2011) An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses. J Virol 85: 6557–6566. doi: 10.1128/JVI.00073-11 21490090
64. Rodriguez-Torres M, Rodriguez-Orengo JF, Rios-Bedoya CF, Fernandez-Carbia A, Salgado-Mercado R, et al. (2006) Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients. Dig Dis Sci 51: 161–167. 16416230
65. Bajaj JS, Heuman DM, Sanyal AJ, Hylemon PB, Sterling RK, et al. (2013) Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One 8: e60042. doi: 10.1371/journal.pone.0060042 23565181
66. Tenorio AR, Chan ES, Bosch RJ, Macatangay BJ, Read SW, et al. (2015) Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy—ACTG A5286. J Infect Dis 211: 780–790. doi: 10.1093/infdis/jiu515 25214516
67. Klatt NR, Canary LA, Sun X, Vinton CL, Funderburg NT, et al. (2013) Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. J Clin Invest 123: 903–907. doi: 10.1172/JCI66227 23321668
68. Pandrea I, Landay A, Wilson C, Stock J, Tracy R, et al. (2015) Using the pathogenic and nonpathogenic nonhuman primate model for studying non-AIDS comorbidities. Curr HIV/AIDS Rep 12: 54–67. doi: 10.1007/s11904-014-0245-5 25604236
69. Sandler NG, Bosinger SE, Estes JD, Zhu RT, Tharp GK, et al. (2014) Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511: 601–605. doi: 10.1038/nature13554 25043006
70. National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
71. Pandrea I, Gaufin T, Gautam R, Kristoff J, Mandell D, et al. (2011) Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion. PLoS Pathog 7: e1002170. doi: 10.1371/journal.ppat.1002170 21829366
72. Pandrea I, Kornfeld C, Ploquin MJ, Apetrei C, Faye A, et al. (2005) Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol 79: 6249–6259. 15858009
73. Pandrea I, Ribeiro RM, Gautam R, Gaufin T, Pattison M, et al. (2008) Simian immunodeficiency virus SIVagm dynamics in African green monkeys. J Virol 82: 3713–3724. doi: 10.1128/JVI.02402-07 18216122
74. Pandrea I, Apetrei C, Dufour J, Dillon N, Barbercheck J, et al. (2006) Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts. J Virol 80: 4858–4867. 16641277
75. Gautam R, Gaufin T, Butler I, Gautam A, Barnes M, et al. (2009) Simian immunodeficiency virus SIVrcm, a unique CCR2-tropic virus, selectively depletes memory CD4+ T cells in pigtailed macaques through expanded coreceptor usage in vivo. J Virol 83: 7894–7908. doi: 10.1128/JVI.00444-09 19493994
76. Rickles FR, Patierno S, Fernandez PM, (2003) Tissue factor, thrombin, and cancer. Chest 124: 58S–68S. 12970125
77. Fernandez PM, Patierno SR, Rickles FR, (2004) Tissue factor and fibrin in tumor angiogenesis. Semin Thromb Hemost 30: 31–44.
78. Alkanani AK, Hara N, Gottlieb PA, Ir D, Robertson CE, et al. (2015) Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes.
79. Dillon SM, Lee EJ, Kotter CV, Austin GL, Dong Z, et al. (2014) An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol 7: 983–994. doi: 10.1038/mi.2013.116 24399150
80. Markle JG, Frank DN, Adeli K, von Bergen M, Danska JS, (2014) Microbiome manipulation modifies sex-specific risk for autoimmunity. Gut Microbes 5: 485–493. doi: 10.4161/gmic.29795 25007153
81. Frank JA, Reich CI, Sharma S, Weisbaum JS, Wilson BA, et al. (2008) Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes. Appl Environ Microbiol 74: 2461–2470. doi: 10.1128/AEM.02272-07 18296538
82. Lane DJ, Field KG, Olsen GJ, Pace NR, (1988) Reverse transcriptase sequencing of ribosomal RNA for phylogenetic analysis. Methods Enzymol 167: 138–144. 2467178
83. Pruesse E, Peplies J, Glockner FO, (2012) SINA: accurate high-throughput multiple sequence alignment of ribosomal RNA genes. Bioinformatics 28: 1823–1829. doi: 10.1093/bioinformatics/bts252 22556368
84. Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, et al. (2013) The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41: D590–596. doi: 10.1093/nar/gks1219 23193283
85. Robertson CE, Harris JK, Wagner BD, Granger D, Browne K, et al. (2013) Explicet: graphical user interface software for metadata-driven management, analysis and visualization of microbiome data. Bioinformatics 29: 3100–3101. doi: 10.1093/bioinformatics/btt526 24021386
86. Oksanen J (2008) Vegan: Community ecology package. R package version 115–1 http://veganr-forger-projectorg.
87. Nadkarni MA, Martin FE, Jacques NA, Hunter N, (2002) Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148: 257–266. 11782518
88. Frank DN, Amand AL, StFeldman RA, Boedeker EC, Harpaz N, et al. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104: 13780–13785. 17699621
89. Pinheiro JC, Bates DM, (2002) Mixed-effects models in S and S-plus. New York, NY: Springer-Verlag.